SENORES · Health Care · 2026-08-21

Senores Pharmaceuticals Ltd

7.8★★ GoodStrong +6.1Stage 2 · wk 17In scan: Prop Scan · Pullback HunterMARKET: BULL RISING · 2026-08-21
₹1,513.3
+0.00% today
₹6,969 Cr · Mid cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.

Visit company website →
P/E (TTM)
42.3
Forward 25.8
Earnings Growth (YoY)
+108.9%
Revenue +53.4%
ROE
+13.8%
Profit margin +18.4%
vs 52W High
-2.4%
₹673.6 lo₹1,550.9 hi
2.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 17
1w13w26w
Week 17 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
54.4%
200 DMA: ₹980.4 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.28x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +3.0% vs MA50 +10.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #6 of 84 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #6 of 58 Stage 2 stocks in this industry. Top tier.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2024-12-30 → 2026-08-21
S? 41w
S2 21w
S2 17w
2024-12-302026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 41w → S2 21w → S3 6w → S2 17w current
Total tracked: 86 weeks across 4 stage runs.
1M
+8.4%
3M
+36.2%
6M
+90.6%
YTD
+82.8%
1Y
+122.4%
Scan Membership
Prop Scan
Latest: 2026-08-21
Pullback Hunter
Latest: 2026-08-21
60 appearances in last 60 days. First seen: 2026-06-25.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 17 · Vol —x
2026-08-20S2
Wk 17 · Vol —x
2026-08-19S2
Wk 17 · Vol —x
2026-08-18S2
Wk 17 · Vol —x
2026-08-17S2
Wk 16 · Vol —x
2026-08-14S2
Wk 16 · Vol —x
2026-08-13S2
Wk 16 · Vol —x
2026-08-12S2
Wk 16 · Vol —x
2026-08-11S2
Wk 16 · Vol —x
2026-08-10S2
Wk 15 · Vol —x
2026-08-07S2
Wk 15 · Vol —x
2026-08-06S2
Wk 15 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹1,381.6
200 DMA
₹980.4
52W High
₹1,550.9
52W Low
₹673.6
5D Low
₹1,513.3
Resistance levels (recent highs)
20d High
₹1,550.9
60d High
₹1,550.9
120d High
₹1,550.9
250d High
₹1,550.9
Next resistance
+2.5%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.